Cargando…
The implementation of drug reposition for alcoholic hepatitis based on a sub-pathway integration strategy
BACKGROUND: Alcoholic hepatitis (AH) is one of the most severe forms of liver disease. The therapies which are currently available are not entirely effective, and thus novel therapies are urgently needed. However, the development of these novel therapies is limited due to incomplete information abou...
Autores principales: | Qi, Wei, Wang, Bing, Yang, Ming, Zhu, Lin, Hu, Sen, Sun, Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7154418/ https://www.ncbi.nlm.nih.gov/pubmed/32309355 http://dx.doi.org/10.21037/atm.2020.01.36 |
Ejemplares similares
-
Repositioning of Anti-Inflammatory Drugs for the Treatment of Cervical Cancer Sub-Types
por: Kori, Medi, et al.
Publicado: (2022) -
Drug repositioning in drug discovery of T2DM and repositioning potential of antidiabetic agents
por: Zhu, Sha, et al.
Publicado: (2022) -
Drug Repositioning in Glioblastoma: A Pathway Perspective
por: Tan, Sze Kiat, et al.
Publicado: (2018) -
A review of validation strategies for computational drug repositioning
por: Brown, Adam S, et al.
Publicado: (2016) -
Mining integrated semantic networks for drug repositioning opportunities
por: Mullen, Joseph, et al.
Publicado: (2016)